Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It is not intended to diagnose, treat or cure any health-related condition
The same molecule may exist in different branded forms, each with its own approved use, dosing range, and clinical narrative
Comparison of Administration Methods To make it clearer, heres a breakdown of how these two approaches stack up in a research context
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not purely a GLP-1 agent
TB-500 is dosed less frequently, typically once or twice per week during a loading phase and once every two weeks during maintenance, reflecting its longer half-life and systemic distribution pattern
Reljanovic M, Reichel G, Rett K, et al
US$ 26.33
US$ 20.88
US$ 26.64
US$ 20.94
US$ 26.40
US$ 25.79
US$ 24.39
US$ 21.82
US$ 25.61
US$ 26.12
